QQQ   290.66 (-1.89%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.66 (-1.89%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.66 (-1.89%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.66 (-1.89%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
NASDAQ:LEGN

Legend Biotech - LEGN Price Target & Analyst Ratings

$50.13
-2.58 (-4.89%)
(As of 01/30/2023 04:20 PM ET)
Add
Compare
Today's Range
$50.03
$53.11
50-Day Range
$46.60
$57.37
52-Week Range
$30.75
$57.72
Volume
815,338 shs
Average Volume
759,818 shs
Market Capitalization
$8.23 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$70.14

Legend Biotech Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 10 Analyst Ratings

Consensus Analyst Price Target

$70.14
39.92% Upside
High Prediction$78.00
Average Prediction$70.14
Low Prediction$65.00
TypeCurrent
1/30/22 to 1/30/23
1 Month Ago
12/31/21 to 12/31/22
3 Months Ago
11/1/21 to 11/1/22
1 Year Ago
1/30/21 to 1/30/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
9 Buy rating(s)
7 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$70.14$67.71$66.20$60.67
Predicted Upside39.92% Upside47.77% Upside54.95% Upside16.75% Upside
Get Legend Biotech Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.


LEGN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LEGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Legend Biotech Stock vs. The Competition

TypeLegend BiotechMedical CompaniesS&P 500
Consensus Rating Score
2.90
2.64
2.46
Consensus RatingModerate BuyBuyHold
Predicted Upside33.07% Upside3,454.52% Upside10.40% Upside
News Sentiment RatingPositive News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/25/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$53.00 ➝ $65.00+19.86%
1/24/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$60.00 ➝ $65.00+20.41%
12/20/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$72.00 ➝ $78.00+54.12%
12/6/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$61.00 ➝ $65.00+27.48%
12/6/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$66.00+29.44%
11/1/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
11/1/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
10/31/2022Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
7/8/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kostas Biliouris
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$77.00+37.38%
3/1/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$65.00 ➝ $75.00+89.44%
8/11/2020Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Biren Amin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$47.00+49.25%
(Data available from 1/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












LEGN Price Target - Frequently Asked Questions

What is Legend Biotech's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for Legend Biotech stock is Moderate Buy based on the current 1 hold rating and 9 buy ratings for LEGN. The average twelve-month price prediction for Legend Biotech is $70.14 with a high price target of $78.00 and a low price target of $65.00. Learn more on LEGN's analyst rating history.

Do Wall Street analysts like Legend Biotech more than its competitors?

Analysts like Legend Biotech more than other Medical companies. The consensus rating for Legend Biotech is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how LEGN compares to other companies.

Does Legend Biotech's stock price have much upside?

According to analysts, Legend Biotech's stock has a predicted upside of 35.43% based on their 12-month price targets.

What analysts cover Legend Biotech?

Legend Biotech has been rated by Barclays, Cowen, Cowen, Evercore ISI, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, and UBS Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:LEGN) was last updated on 1/30/2023 by MarketBeat.com Staff